Did Tesaro Just Enter Yet Another Overcrowded Space?
Two Small Biotech Stocks Identified As Potential M&A TargetsOct. 10, 2015 • Bret Jensen • 6 Comments
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.
TESARO, Inc. engages in the research and development of biopharmaceutical products. It focuses on oncology-based therapeutics and consists of the following portfolio: Rolapitant IV and Niraparib. The company was founded by Leon Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26,... More
Country: United States
Other News & PR